Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07408245 · ClinicalTrials.gov registry record · NA
Effects of Biocidin on Oral Biofilms
A NA study of Biofilm, sponsored by OvationLab.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07408245 is a NA study of Biofilm that is actively recruiting participants, run by OvationLab. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07408245, a NA study of Biofilm, is actively recruiting participants, sponsored by OvationLab.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of this study is to evaluate the effects of Biocidin liquid on oral biofilms among healthy adults. A single-arm, open-label prospective study will be conducted evaluating the impact of two weeks of supplementation with label dosing of Biocidin liquid on oral biofilms as assessed by SimplyPERIO (Spectrum Solutions, Salt Lake City, UT).
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Biocidin Liquid
Study Locations (1)
Virginia
- OvationLab - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-02-17 |
| Est. Completion | 2026-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07408245
The ClinicalTrials.gov registry entry for NCT07408245 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OvationLab, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Biofilm appearing as the primary indexed condition, and to 1 intervention - of which Biocidin Liquid is the first listed.
NCT07408245 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT07408245 about?
NCT07408245 is a clinical study titled "Effects of Biocidin on Oral Biofilms". The primary purpose of this study is to evaluate the effects of Biocidin liquid on oral biofilms among healthy adults. A single-arm, open-label prospective study will be conducted evaluating the impact of two weeks of supplementation with label dosing of Biocidin liquid on oral biofilms as assessed ...
What is the current status of trial NCT07408245?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-02-17. Estimated completion is 2026-04.
What conditions does trial NCT07408245 study?
This clinical trial studies the following conditions: Biofilm.
What interventions are being tested in trial NCT07408245?
The interventions under investigation include: Biocidin Liquid (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07408245?
This trial is sponsored by OvationLab, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07408245 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.